(Q3)Apr 30, 2024 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | |
---|---|---|---|
Operating Cash Flow (Indirect Method) | |||
Cash flow from continuing operating activities | 447.11%53.14K | -92.33K | -15.31K |
Net income from continuing operations | -660.01%-349.86K | ---165.32K | ---46.03K |
Depreciation and amortization | --1.33K | --1.14K | --0 |
Remuneration paid in stock | ---- | ---- | --0 |
Change In working capital | 925.60%315.13K | --71.86K | --30.73K |
-Change in receivables | 158.57%4.1K | --6.96K | ---7K |
-Change in payables and accrued expense | 724.46%311.03K | --64.9K | --37.73K |
Cash from discontinued investing activities | |||
Operating cash flow | 447.11%53.14K | ---92.33K | ---15.31K |
Investing cash flow | |||
Cash flow from continuing investing activities | -929.30%-328.55K | -281.16K | -31.92K |
Net PPE purchase and sale | -929.30%-328.55K | ---281.16K | ---31.92K |
Cash from discontinued investing activities | |||
Investing cash flow | -929.30%-328.55K | ---281.16K | ---31.92K |
Financing cash flow | |||
Cash flow from continuing financing activities | 1.51M | 150K | |
Net common stock issuance | ---- | --1.21M | --150K |
Cash from discontinued financing activities | |||
Financing cash flow | ---- | --1.51M | --150K |
Net cash flow | |||
Beginning cash position | --664K | --102.77K | --0 |
Current changes in cash | -367.99%-275.42K | --1.13M | --102.77K |
End cash Position | 278.11%388.59K | --1.24M | --102.77K |
Free cash from | -483.16%-275.42K | ---373.48K | ---47.23K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data